Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

RFT5-dgA immunotoxin

(... IH-myoo-noh-TOK-sin)
A monoclonal antibody linked to a toxic substance. It is being studied in the treatment of melanoma that has spread to distant parts of the body. RFT5-dgA immunotoxin is made in the laboratory. It can find and kill certain white blood cells that prevent the immune system from killing cancer cells. Also called IgG-RFT5-dgA.
Search NCI's Dictionary of Cancer Terms